Who Owns Alector Stock?
NASDAQ: ALECHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 2:57 PM ET
Ownership breakdown
- Held by institutions
- 93.29%
- Institutions (% of float)
- 103.10%
- Held by insiders
- 9.52%
- Institutional holders
- 189
- Institutions 90.5%
- Insiders 9.5%
- Public and other 0.0%
Who owns Alector stock?
Institutional investors own about 93.3% of Alector's shares, spread across 189 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 9.52% of ALEC.
The largest institutional holders are TCG Crossover Management, LLC (8.96%), Blackrock Inc. (7.03%) and Acadian Asset Management. LLC (3.95%). Together, the top 10 institutions control 42.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ALEC positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALEC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| TCG Crossover Management, LLC | 10.00M | 8.96% | 0.0% |
| Blackrock Inc. | 7.85M | 7.03% | +1.4% |
| Acadian Asset Management. LLC | 4.41M | 3.95% | +9.3% |
| Nantahala Capital Management, LLC | 4.32M | 3.87% | +53.3% |
| Vanguard Capital Management LLC | 4.01M | 3.59% | +9.0% |
| Kynam Capital Management, LP | 3.81M | 3.41% | +90.4% |
| Merck & Co., Inc. | 3.55M | 3.18% | 0.0% |
| Balyasny Asset Management LP | 3.25M | 2.91% | +10.6% |
| 683 Capital Management LLC | 3.20M | 2.87% | 0.0% |
| Shaw D.E. & Co., Inc. | 2.96M | 2.65% | -11.2% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALEC
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.84M | 2.54% |
| iShares Trust-iShares Russell 2000 ETF | 2.51M | 2.25% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.38M | 1.24% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.07M | 0.96% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.03M | 0.93% |
| iShares Trust-iShares Russell 2000 Growth ETF | 827.21K | 0.74% |
| Vanguard Explorer Fund | 673.49K | 0.60% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 635.41K | 0.57% |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Small-Cap Equity Fund | 628.63K | 0.56% |
| VANGUARD VARIABLE INSURANCE FUNDS-Small Company Growth Portfolio | 615.92K | 0.55% |
Frequently asked questions
Who is the largest shareholder of Alector?
TCG Crossover Management, LLC is the largest institutional shareholder of ALEC, owning 8.96% of shares outstanding (10.00M shares) as of its latest 13F filing.
What percentage of Alector is owned by institutions?
Institutions own about 93.3% of ALEC shares and 103.1% of the public float.
How much of Alector do insiders own?
Insiders, such as officers and directors, own about 9.52% of ALEC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.